Current with changes from the 2024 Legislative Session
Section 15-1611 - Information on and sales of prescription drugs(a) This section applies only to a pharmacy benefits manager that provides pharmacy benefits management services on behalf of a carrier.(b) A pharmacy benefits manager may not prohibit a pharmacy or pharmacist from: (1) providing a beneficiary with information regarding the retail price for a prescription drug or the amount of the cost share for which the beneficiary is responsible for a prescription drug;(2) discussing with a beneficiary information regarding the retail price for a prescription drug or the amount of the cost share for which the beneficiary is responsible for a prescription drug; or(3) if a more affordable drug is available than one on the purchaser's formulary and the requirements for a therapeutic interchange under §§ 15-1633.1 through 15-1639 of this subtitle are met, selling the more affordable alternative to the beneficiary.(c) This section may not be construed to alter the requirements for a therapeutic interchange under §§ 15-1633.1 through 15-1639 of this subtitle.Amended by 2021 Md. Laws, Ch. 358,Sec. 1, eff. 1/1/2022.Added by 2018 Md. Laws, Ch. 451,Sec. 1, eff. 6/1/2018.